Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIOngoingJul 2, 2025Azelastine HCl Ophthalmic SolutionLack of Assurance of SterilityApotex Corp. · D-0495-2025Class IIOngoingJul 2, 2025Ketorolac Tromethamine Ophthalmic SolutionLack of Assurance of SterilityApotex Corp. · D-0494-2025Class IIOngoingJul 2, 20250.9% Sodium Chloride Injection USPLack of assurance of sterility: pinholes, within the finger boxes used during Form Fill Seal process resulting in leaks.B Braun Medical Inc · D-0491-2025Class IIOngoingJul 2, 20250.9% Sodium Chloride InjectionLack of Assurance of SterilityFresenius Medical Care Holdings, Inc. · D-0490-2025Class IIOngoingJul 2, 2025DOBUTamine InjectionDiscoloration; discolored solution from cracked vialsPfizer Inc. · D-0489-2025Class IIOngoingJul 2, 2025Nicotinamide adenine dinucleotideLack of Assurance of SterilityThrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · D-0487-2025Class IIOngoingJul 2, 2025Tirzepatide/Cyanocobalamin InjectableLack of Assurance of SterilityThrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · D-0486-2025Class IIOngoingJul 2, 2025Tirzepatide/Cyanocobalamin InjectableLack of Assurance of SterilityThrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · D-0485-2025Class IIOngoingJul 2, 2025Tirzepatide InjectionsLack of Assurance of SterilityThrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · D-0484-2025Class IIOngoingJul 2, 2025Tirzepatide InjectionsLack of Assurance of SterilityThrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · D-0483-2025Class IIOngoingJul 2, 2025Tirzepatide InjectionsLack of Assurance of SterilityThrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · D-0482-2025Class IIOngoingJul 2, 2025Semaglutide/Cyanocobalamin InjectableLack of Assurance of SterilityThrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · D-0481-2025Class IIOngoingJul 2, 2025SemaglutideLack of Assurance of SterilityThrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · D-0480-2025Class IIOngoingJul 2, 2025SemaglutideLack of Assurance of SterilityThrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · D-0479-2025Class IIOngoingJul 2, 2025Nicotinamide adenine dinucleotideLack of Assurance of SterilityThrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · D-0478-2025Class IIOngoingJul 2, 2025LX Bioboost PlusLack of Assurance of SterilityThrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · D-0477-2025Class IIOngoingJul 2, 2025LL Bioboost InjectableLack of Assurance of SterilityThrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · D-0476-2025Class IIOngoingJul 2, 2025CJC-1295 InjectableLack of Assurance of SterilityThrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · D-0475-2025Class IIOngoingJul 2, 2025Methylcobalamin InjectableLack of Assurance of SterilityThrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) · D-0474-2025Class IIOngoingJul 2, 2025Metoclopramide TabletsPresence of foreign tablets/capsules.Teva Pharmaceuticals USA, Inc · D-0473-2025Class ICompletedJun 25, 2025UMOVY ACIDO HIALURONICOMarketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone and Diclofenac.Umary-USA.com · D-0493-2025Class ICompletedJun 25, 2025UNAVY ACIDO HIALURONICOMarketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.Umary-USA.com · D-0492-2025Class IIOngoingJun 25, 2025Gentamicin InjectionFailed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.Eugia US LLC · D-0472-2025Class IIOngoingJun 25, 2025Acetaminophen TabletscGMP deviations: Due to confirmed consumer complaints received with the observation of tablet discoloration (brown surface on tablets).Aurobindo Pharma USA Inc · D-0471-2025Class IICompletedJun 18, 2025Icosapent Ethyl Capsules 1 gramFailed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of...Zydus Pharmaceuticals (USA) Inc · D-0497-2025Class IOngoingJun 18, 2025Sulfamethoxazole and Trimethoprim TabletsMicrobial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination.Amneal Pharmaceuticals, LLC · D-0488-2025Class IIIOngoingJun 18, 2025Levothyroxine Sodium TabletsPresence of a foreign substance: black hair found embedded in tablet.Macleods Pharmaceuticals Ltd · D-0470-2025Class IIOngoingJun 18, 2025Cephalexin for Oral SuspensionFailed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis. The...Ascend Laboratories, LLC · D-0469-2025Class IIOngoingJun 18, 2025Cephalexin for Oral SuspensionFailed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis. The...Ascend Laboratories, LLC · D-0468-2025Class IOngoingJun 18, 2025Male Ultra ProMarketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.Saini Trade Inc · D-0467-2025Class IOngoingJun 18, 2025ULTRA ARMORMarketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.Saini Trade Inc · D-0466-2025Class IOngoingJun 18, 2025ELECTRO BUZZMarketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared chloropretadalafil, propoxyphenylsildenafil, and sildenafil.Saini Trade Inc · D-0465-2025Class IOngoingJun 18, 2025MALEXTRAMarketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.Saini Trade Inc · D-0464-2025Class IOngoingJun 18, 2025Male UltraMarketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.Saini Trade Inc · D-0463-2025Class IIIOngoingJun 18, 2025Ezetimibe and Simvastatin TabletsFailed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time point during long-term...Glenmark Pharmaceuticals Inc., USA · D-0462-2025Class IIOngoingJun 18, 2025Chlorthalidone TabletsFailed Dissolution SpecificationsAvKARE · D-0461-2025Class IIOngoingJun 18, 2025Celecoxib CapsulesPresence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200 mg capsulesAvKARE · D-0460-2025Class IIOngoingJun 18, 2025Celecoxib CapsulesPresence of Foreign Tablets/Capsules; customer complaint found one Tadalafil 5mg tablet inside a sealed 500-count bottle of Celecoxib 200mg capsuleAlembic Pharmaceuticals Limited · D-0459-2025Class IIOngoingJun 11, 2025Spectrum Advanced Gel Hand SanitizerSubpotent product: Product has cloudy appearance and tested below assay label claim for 70% Ethyl AlcoholConsumer Product Partners, LLC · D-0458-2025Class IIOngoingJun 11, 2025Lacosamide Oral SolutionDefective Container: This recall is being initiated due to a leaking unit stored horizontally.Apotex Corp. · D-0457-2025

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.